BIOTECH INVESTMENT ANALYST - SPECIALIST FUND

About the job Mercor connects elite creative and technical talent with leading AI research labs. Headquartered in San Francisco, our investors include Benchmark , General Catalyst , Peter Thiel , Adam D'Angelo , Larry Summers , and Jack Dorsey . Position: Biotech Investment Analyst — Drug Asset & Company Assessment Type: Contract Compensation: $125–$200/hour Location: Remote Duration: 1–2 week pilot Role Responsibilities • Create and critique rubrics that analyze commercial drugs and drug-development programs. • Provide overall company and asset assessment, including mechanism, clinical data, competitive position, and value drivers. • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions. • Apply your assessment across the pilot's set of companies, approximately 5–10. • Work independently and asynchronously to meet deadlines while improving AI model performance . Qualifications Must-Have • US-based biotech/healthcare investment analyst with a specialist-fund background. • Familiarity with biotech/pharma development programs. • Able to assess a drug asset and the company behind it end-to-end. • 5+ years evaluating biotech/pharma companies or assets. Compensation & Legal • Hourly contractor Application Process (Takes 20–30 mins to complete) • Upload resume • AI interview based on your resume • Submit form Resources & Support • For details about the interview process and platform information, please check: https://talent.docs.mercor.com/welcome • For any help or support, reach out to: support@mercor.com PS: Our team reviews applications daily. Please complete your AI interview and application steps to be considered for this opportunity.